Every parent wants the best start for their baby. Non-Invasive Prenatal Testing (NIPT) is one of the most powerful tools available to expecting parents — offering a safe, accurate window into your baby’s chromosomal health from as early as week 10 of pregnancy.
What is NIPT?
NIPT analyses cell-free foetal DNA (cfDNA) circulating in the mother’s blood to screen for chromosomal abnormalities. It is non-invasive — requiring only a simple maternal blood draw — and carries no risk to the baby.
What Does NIPT Screen For?
- Trisomy 21 (Down Syndrome) — the most common chromosomal condition
- Trisomy 18 (Edwards Syndrome) — associated with severe developmental delays
- Trisomy 13 (Patau Syndrome) — associated with serious physical and intellectual disabilities
- Sex Chromosome Abnormalities — including Turner syndrome (45,X) and Klinefelter syndrome (47,XXY)
- Microdeletions — small chromosomal deletions associated with conditions like DiGeorge syndrome (optional add-on)
How Accurate is NIPT?
NIPT has a detection rate of over 99% for trisomy 21, with a very low false-positive rate. It is significantly more accurate than traditional first-trimester screening (nuchal translucency + blood tests). A positive NIPT result should be confirmed with a diagnostic test such as amniocentesis or CVS.
When Should You Do NIPT?
NIPT can be performed from week 10 of pregnancy onwards. Earlier testing gives you more time to process results, seek genetic counselling, and make informed decisions about your pregnancy.
Who Should Consider NIPT?
- All pregnant women, regardless of age or risk level
- Women over 35 (advanced maternal age increases chromosomal risk)
- Those with a family history of chromosomal conditions
- Those with abnormal first-trimester screening results
- Those who have had a previous pregnancy affected by a chromosomal condition
Conclusion
NIPT is a safe, accurate, and early window into your baby’s chromosomal health. Combined with genetic counselling, it empowers expecting parents with the information they need to make informed decisions and prepare for the journey ahead.
Screen Your Baby’s Chromosomal Health from Week 10
MapmyGenome’s NIPT screens for Down syndrome, Edwards syndrome, Patau syndrome, and sex chromosome abnormalities — from a simple maternal blood draw. NABL & CAP accredited lab. Genetic counselling included.
